3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
Oxaliplatin
24
Capecitabine
24
Paclitaxel
23
Gemcitabine
21
Cisplatin
21
Fluorouracil
20
Drug Therapy
18
Carboplatin
18
Docetaxel
17
pembrolizumab
15
Leucovorin
15
Irinotecan
15
Radiotherapy
12
tislelizumab
11
Magnetic Resonance Spectroscopy
10
Injections
10
Pemetrexed
9
Bevacizumab
9
Specimen Handling
8
Radiation
8
Cetuximab
8
toripalimab
7
Surgical Procedures, Operative
7
Radiotherapy, Intensity-Modulated
7
Azacitidine
7
venetoclax
6
sintilimab
6
atezolizumab
6
Topotecan
6
Cyclophosphamide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Not yet recruiting
×
quizartinib
×
Clear all
NCT07478991
2026-03-18
VENP-A-QUI
PETHEMA Foundation
Phase 3
Not yet recruiting
376 enrolled